Creative Planning
AURA icon

Creative Planning’s Aura Biosciences AURA Stock Holding History

Creative Planning’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
15,472
+1,399
+10% +$10K ﹤0.01% 4028
2026
Q1 		$94.1K Buy
14,073
+2,779
+25% +$15.9K ﹤0.01% 3917
2025
Q4 		$61.6K Buy
+11,294
New +$67.1K ﹤0.01% 3781
2025
Q2 		– Sell
-10,157
Closed -$59.5K – 3687
2025
Q1 		$59.5K Sell
10,157
-11,258
-53% -$85.2K ﹤0.01% 3326
2024
Q4 		$176K Buy
+21,415
New +$202K ﹤0.01% 3011

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Creative Planning's AURA Position: Q2 2026 in Review

Creative Planning increased its Aura Biosciences (AURA) stake by 9.9% in Q2 2026, buying an estimated $10K and bringing the position to 15,472 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #4028.

Creative Planning first reported a position in AURA in Q4 2024 and has held it in 5 quarters since. The position peaked at $176K in Q4 2024. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Creative Planning held 15,472 shares of Aura Biosciences worth $110K as of Q2 2026.
  • Creative Planning bought 1,399 Aura Biosciences shares in Q2 2026, an estimated $10K.
  • Aura Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4028 holding.
  • Creative Planning first reported a position in Aura Biosciences in Q4 2024 and has held it in 5 quarters since.
  • Creative Planning's Aura Biosciences position peaked at $176K in Q4 2024.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.